Searched for: subject%3A%22Caprolactone%22
(1 - 3 of 3)
Kuhnt, T. (author), marroquín García, R. (author), Camarero-Espinosa, S. (author), Dias, A. (author), ten Cate, A.T. (author), van Blitterswijk, C.A. (author), Moroni, L. (author), Baker, M.B. (author)
To exploit the usability of Digital Light Processing (DLP) in regenerative medicine, biodegradable, mechanically customizable and well-defined polyester urethane acrylate resins were synthesized based on poly(caprolactone-co-trimethlenecarbonate). By controlling the monomer ratio, the resultant fabricated constructs showed tunable mechanical...
article 2019
Balguid, A. (author), Mol, A. (author), van Marion, M.H. (author), Bank, R.A. (author), Bouten, C.V.C. (author), Baaijens, F.P.T. (author), TNO Kwaliteit van Leven (author)
Despite the attractive features of nanofibrous scaffolds for cell attachment in tissue-engineering (TE) applications, impeded cell ingrowth has been reported in electrospun scaffolds. Previous findings have shown that the scaffold can function as a sieve, keeping cells on the scaffold surface, and that cell migration into the scaffold does not...
article 2009
Pires, N.M.M. (author), van der Hoeven, B.L. (author), de Vries, M.R. (author), Havekes, L.M. (author), van Vlijmen, B.J. (author), Hennink, W.E. (author), Quax, P.H.A. (author), Jukema, J.W. (author), TNO Kwaliteit van Leven (author)
The introduction of drug-eluting stents (DES) to prevent in-stent restenosis is one of the major advances in interventional cardiology. Currently many types of DES are under evaluation for effectiveness and safety, a time-consuming and difficult procedure in humans. An animal model that allows rapid evaluation of the present and upcoming...
article 2005